| Title： | Expert Consensus on Homogenization Construction of Traditional Chinese Medicine Prescription Review in National Traditional Chinese Medicine Regional Medical Center |
| Edition： | Others |
| Classification： | Traditional Chinese Medicine guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Pharmacists and health administrative personnel in medical institutions |
| Evidence classification method： | Improved Delphi Evidence Grading Method |
| Development unit： | Xiyuan Hospital of China Academy of Chinese Medical Sciences |
| Registration time: | 2023-11-20 |
| Registration number： | PREPARE-2023CN920 |
| Purpose of the guideline: | Prescription review and prescription comment of traditional Chinese patent medicines and simple preparations is an important part of the pharmaceutical affairs management of medical institutions, which is of great significance to the level of rational drug use of medical institutions. However, at present, different medical institutions have different working modes and review and comment rules, reducing the expected effect. This consensus relies on the National Traditional Chinese Medicine Regional Medical Center to carry out the homogenization construction and standard sharing of rules for the review and evaluation of traditional Chinese medicine prescriptions, providing support for solving the above problems. |
Latest registration
